Kelly R. Hume
Veterinary medical oncology; chemotherapy; DNA damage responses; genomic instability
Current Research Interest
How the DNA damage response gene Hus1 affects lung tumorigenesis and chemosensitivity; DNA damage response proteins as biomarkers of chemosensitivity and therapeutic targets; drug repurposing for affordable cancer therapies
Bing, Yike, Zacharie Wund, Tina Abratte, Lucia Borlle, Susie Kang, Teresa Southard, and Kelly R. Hume. “Biological Indicators of Chemoresistance: An Ex Vivo Analysis of γH2AX and p53 Expression in Feline Injection Site Sarcoma.” Cancer Cell International 18 (2018):192.
Davis, Lillie L., Kelly R. Hume, and Tracy Stokol. “A Retrospective Review of Acute Myeloid Leukaemia in 35 Dogs Diagnosed by a Combination of Morphologic Findings, Flow Cytometric Immunophenotyping and Cytochemical Staining Results (2007-2015).” Veterinary and Comparative Oncology 16 (2018): 268-275.